Companies / India
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Ranbaxy Eyes US Expansion?
October 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Ranbaxy appears looks set to continue its aggressive expansion strategy, with speculation linking the company to a move for US generics firm URL/Mutual Pharmaceuticals. Ranbaxy has already completed a number of acquisitions in Europe this year including the purchase of GlaxoSmithKline (GSK)'s generics businesses in Spain and Italy, as well as Romanian pharmaceutical company